Should a patient with a mechanical aortic valve receive antibiotic prophylaxis and peri‑operative anticoagulation management before an invasive procedure?

Peri-Procedural Management of Mechanical Aortic Valves

For patients with a mechanical aortic valve undergoing an invasive procedure, antibiotic prophylaxis is NOT routinely recommended for most procedures, but peri-operative anticoagulation management is essential and depends on thromboembolism risk stratification.

Antibiotic Prophylaxis

Antibiotic prophylaxis is only indicated for specific high-risk dental procedures in patients with prosthetic valves, not for routine invasive procedures. 1

• High-risk dental procedures requiring prophylaxis include manipulation of gingival or peri-apical region of teeth or perforation of oral mucosa (scaling, root canal procedures). 1
• Recommended regimen: Amoxicillin 2g PO or IV as a single dose before the procedure (or clindamycin 600mg if penicillin allergic). 1
• Prophylaxis is NOT recommended for gastrointestinal, genitourinary, respiratory tract, dermatological, or musculoskeletal procedures. 1

Peri-Operative Anticoagulation Management

The approach depends on thromboembolism risk stratification based on valve type, location, and patient risk factors:

Low-Risk Patients (Bileaflet Mechanical AVR, No Risk Factors)

For low-risk patients, warfarin interruption WITHOUT bridging anticoagulation is recommended. 2, 3

• Stop warfarin 48-72 hours (or 3-4 days) before the procedure to achieve INR <1.5. 4, 2
• No bridging therapy with heparin is necessary. 4, 3
• Restart warfarin within 24 hours after the procedure when bleeding risk allows. 4, 2
• Continue warfarin for minor procedures (dental extractions, cataract surgery) where bleeding is easily controlled. 2, 3

High-Risk Patients Requiring Bridging

Bridging anticoagulation is reasonable for patients with: 2

1. Mechanical AVR with ANY thromboembolic risk factor (atrial fibrillation, previous thromboembolism, hypercoagulable state, older-generation valve, LV dysfunction, or >1 mechanical valve) 2, 3
2. Older-generation mechanical AVR (ball-cage or tilting-disc valves) 2, 3
3. Mechanical mitral valve replacement 2, 3

Bridging protocol: 4, 2

• Pre-operatively: Start therapeutic-dose IV unfractionated heparin or subcutaneous LMWH when INR falls below 2.0 (typically 36-48 hours before surgery). 4, 2
• Stop bridging: 4-6 hours before procedure (IV UFH) or 12 hours before (subcutaneous LMWH). 4, 2
• Post-operatively: Restart bridging as early as bleeding stability allows and continue until INR is therapeutic with warfarin. 4

Important Caveats

The 2017 ACC/AHA guidelines downgraded bridging from Class I to Class IIa (from "recommended" to "reasonable"), reflecting emerging concerns about increased bleeding risk without clear thromboembolism benefit. 2 This was based on RCT data from atrial fibrillation patients showing higher bleeding with bridging. 2

However, the 2022 CHEST guidelines and recent PERIOP-2 trial data (which included 20.7% mechanical valve patients) showed no significant difference in thromboembolism between bridging and no-bridging groups, but bridging increased bleeding risk. 5 Despite this, bridging may still be considered in the highest-risk patients (older-generation valves, mechanical mitral valve with risk factors, recent <3 months thromboembolism). 5

Emergency Procedures

For emergency surgery requiring immediate warfarin reversal, administer 4-factor prothrombin complex concentrate (preferred over fresh frozen plasma due to faster onset). 6 Fresh frozen plasma is reasonable as an alternative. 4

Contraindications

Direct oral anticoagulants (DOACs) are absolutely contraindicated in patients with mechanical valves due to increased thrombotic complications and bleeding demonstrated in the RE-ALIGN trial. 3, 2, 3